(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE

Star0

DB08039ExperimentalSmall molecule

(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE: Overview.

Formula / weight: C₁₉H₂₁N₃O₃S · 371.453 g/mol (avg)

Resolves to

Compound

ChEMBLCHEMBL605003PubChem5312137

Structure

InChIKeyLOGJQOUIVKBFGH-YBEGLDIGSA-NSMILESCN(C)S(=O)(=O)C1=CC=C2NC(=O)\C(=C/C3=CC4=C(CCCC4)N3)C2=C1

Targets

Q96GD4AURKBP54619PRKAG1Q9Y478PRKAB1Q13131PRKAA1P06239LCKP12931SRCQ9UQB9AURKCQ13557CAMK2D

What you can answer from here — as of August 31, 2026

9Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

15+ReferencesStructured and connected to the statements they support

Which drugs share a target with (3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account